Role of ribosomal protein S12 in peptide chain elongation: analysis of pleiotropic, streptomycin-resistant mutants of Escherichia coli.

Journal of Bacteriology
J M ZengelM Nomura

Abstract

Some of the spontaneous streptomycin-resistant mutants of Escherichia coli strain C600 exhibit pleiotropic effects in addition to the antibiotic resistance. These effects include decreased growth rates, reduced levels of certain enzymes, and poor support of bacteriophage growth. One of these mutants, strain SM3, was studied further. We have examined the question of whether the reduced growth rate of the mutant SM3 is related to the reduction in relative amounts of ribosomes or to the reduction in the efficiency of ribosomes in protein synthesis. Measurements of alpha, the differential synthesis rate of ribosomal protein, revealed that the protein synthesis effeciency of ribosomes from the mutant strain SM3 was reduced about twofold relative to that of the parent strain C600. Measurements of the induction lag for beta-galactosidase and of the synthesis time of several different molecular-weight classes of proteins indicated that the mutation resulted in a marked reduction in the peptide chain growth rate. This reduction in the chain growth rate probably accounted for most of the observed reduction in the growth rate of the mutant strain. These experimental results show that the strA gene product, the S12 protein of the 30S subu...Continue Reading

References

Aug 12, 1976·Nature·D J Galas, E W Branscomb
Dec 15, 1974·Journal of Molecular Biology·P M Bennett, O Maaloe
Jul 15, 1973·Journal of Molecular Biology·M T HansenK von Meyenburg
Apr 25, 1973·Journal of Molecular Biology·P Strigini, E Brickman
Apr 15, 1974·Journal of Molecular Biology·P P Dennis, H Bremer
Jan 1, 1966·Cold Spring Harbor Symposia on Quantitative Biology·L GoriniL Breckenridge
Jan 1, 1969·Cold Spring Harbor Symposia on Quantitative Biology·M NomuraC V Lowry
Aug 28, 1971·Journal of Molecular Biology·R L CoffmanA L Koch
Dec 14, 1968·Journal of Molecular Biology·H Bremer, D Yuan
Dec 29, 1971·Nature: New Biology·L Gorini
Aug 16, 1965·Biochemical and Biophysical Research Communications·G FairbanksR H Reeder
Jul 14, 1967·Journal of Molecular Biology·R Schleif
Nov 18, 1961·Nature·C R SPOTTS, R Y STANIER
Jun 1, 1962·Journal of General Microbiology·C R SPOTTS
May 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·J DAVIESL GORINI
Sep 1, 1970·Bacteriological Reviews·M Nomura

❮ Previous
Next ❯

Citations

Feb 1, 1986·Molecular & General Genetics : MGG·I DiazC G Kurland
Jan 1, 1984·Molecular & General Genetics : MGG·K BohmanC G Kurland
Feb 1, 1984·Quarterly Reviews of Biophysics·M Ehrenberg, C G Kurland
Jun 27, 2014·The FEBS Journal·Gidi PelchovichUri Gophna
Sep 1, 1979·Molecular & General Genetics : MGG·G R QuanG H Chambliss
May 9, 1996·Nature·S J Schrag, V Perrot
Jan 1, 1983·Molecular & General Genetics : MGG·D I Andersson, C G Kurland
Feb 1, 1991·Molecular Microbiology·J T AndersenP Poulsen
Dec 1, 1994·European Journal of Biochemistry·R Karimi, M Ehrenberg
Dec 31, 2002·The Lancet Infectious Diseases·Ted CohenMegan Murray
Dec 1, 1995·Microbiological Reviews·C CondonC L Squires
Jan 1, 1984·Journal of Bacteriology·T M Henkin, G H Chambliss
Mar 10, 1983·Biochimica Et Biophysica Acta·G McMahon, J V Landau
Feb 1, 1986·Journal of Bacteriology·E R LifsonJ M Zengel
Apr 20, 1992·Journal of Molecular Biology·N BilginM Ehrenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.